Publication not explained

This publication has not yet been explained in plain language by the author(s). However, you can still read the publication.

If you are one of the authors, claim this publication so you can create a plain language summary to help more people find, understand and use it.

Featured Image

Read the Original

This page is a summary of: Efficacy and safety of BG-12 (dimethyl fumarate) and other disease-modifying therapies for the treatment of relapsing–remitting multiple sclerosis: a systematic review and mixed treatment comparison, Current Medical Research and Opinion, November 2013, Informa Healthcare,
DOI: 10.1185/03007995.2013.863755.
You can read the full text:

Read

Contributors

The following have contributed to this page